TipRanks
Go Ultimate55% OFF

Arovella Therapeutics Limited (E4NA) Q4 2023 Earnings Report

DE:E4NA Q4 2023 EPS Results

Actual EPS
EUR 0.00
Consensus EPS
―
Beat/Miss
―
One Year Ago EPS
EUR 0.00

DE:E4NA Q4 2023 Revenue Results

Actual Revenue
EUR 16.05K
Expected Revenue
―
Beat/Miss
―
YoY Revenue Growth
-90.37%

Earnings Announcement Details

Quarter
Q4 2023
Date
08/31/2023
Time
Before Open
Conference Call
Thursday, August 31, 2023

Q4 2023 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q4 2023 Earnings Slide Deck

No slide deck is available for this earnings event.

Q4 2023 Earnings Call Summary

No earnings call summary is available for this earnings event.

DE:E4NA Earnings History

DE:E4NA earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Sep 02, 20262026 (Q4)―-0.00033.33% (+0.00)
Feb 19, 20262026 (Q2)―-0.000-100.00% (-0.00)
Aug 27, 20252025 (Q4)-0.00-0.000-20.00% (-0.00)
Feb 26, 20252025 (Q2)-0.00-0.00075.00% (+0.00)
Aug 21, 20242024 (Q4)―-0.00037.50% (+0.00)
Feb 28, 20242024 (Q2)―-0.00033.33% (+0.00)
Aug 31, 20232023 (Q4)―-0.0000.00% (+0.00)
Feb 22, 20232023 (Q2)―-0.00025.00% (+0.00)
Aug 31, 20222022 (Q4)―-0.000-14.29% (-0.00)
Feb 27, 20222022 (Q2)―-0.00-0.3898.73% (+0.38)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed
Show More